ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Date Title Topic
03 May 2013 Study opens new prospects for developing new targeted therapies for breast cancer Anticancer agents & Biologic therapy , Breast cancer
03 May 2013 Study confirms Everolimus can overcome Trastuzumab resistance in IN HER-2 positive early breast cancer Anticancer agents & Biologic therapy , Breast cancer
03 May 2013 Gene expression test distinguishes between breast cancer patients at high and low risk of late recurrence Breast cancer , Personalised medicine
03 May 2013 Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive beast cancer Breast cancer , Personalised medicine
02 May 2013 Breast cancer heterogeneity no barrier to predictive testing, study shows Breast cancer , Personalised medicine
02 May 2013 Study reveals magnitude of variation in gene expression measurements within breast cancers Breast cancer , Pathology/Molecular biology , Personalised medicine
04 Feb 2013 ESMO supports World Cancer Day cautioning that the era of personalised cancer medicine is not here yet Personalised medicine
28 Jan 2013 ESMO Press Release: Regulators and hospital authorities called upon to avoid unnecessary delays in approving clinical trials - ESMO Commentary Bioethics, legal and economic issues
02 Oct 2012 Equal access to cancer care is a medical and ethical imperative Bioethics, legal and economic issues
01 Oct 2012 Should aspirin be used to prevent cancer? Gastrointestinal cancers
01 Oct 2012 New findings on optimal duration of trastuzumab therapy for women Breast cancer
01 Oct 2012 Phase III data in treatment of renal cell carcinoma reported Anticancer agents & Biologic therapy , Gastrointestinal cancers
01 Oct 2012 First large scale trial of whole-genome cancer testing for clinical decision-making reported Breast cancer
01 Oct 2012 Studies show advances in gastrointestinal cancer treatments Gastrointestinal cancers
01 Oct 2012 New findings highlight the challenges of managing blood clotting in cancer patients Anticancer agents & Biologic therapy , Personalised medicine
30 Sep 2012 Are too few women being offered breast-conserving treatment? Breast cancer
30 Sep 2012 Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer Lung and other thoracic tumours
30 Sep 2012 Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive advanced NSCLC Lung and other thoracic tumours
30 Sep 2012 ESMO 2012 Press Release: New weapons in the fight against cancer Basic science
29 Sep 2012 ESMO 2012 Press Release: Myths and misunderstandings hamper efforts to prevent cancer Cancer prevention
29 Sep 2012 Phase III MISSION trial Lung and other thoracic tumours
29 Sep 2012 Studies show drug combinations effective for melanoma Melanoma
29 Sep 2012 Governments failing to address “global pandemic of untreated cancer pain” Palliative and supportive care
29 Sep 2012 ESMO 2012 Press Release: Many cancer patients unaware of the personalised medicine revolution in oncology, survey shows Personalised medicine
29 Sep 2012 ESMO Congresses in Vienna - what stories previously made a buzz Cancer prevention